Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
366 Leser
Artikel bewerten:
(1)

STEVENSON SEARCH PARTNERS RECEIVES INVESTMENT TO SPUR GROWTH AS A LEADING TALENT SOLUTIONS PROVIDER IN LIFE SCIENCES

Family-owned SixSibs Capital provides funding to meet the need for innovative talent during pivotal time in industry

FORT LEE, N.J. and LONDON, March 5, 2024 /PRNewswire/ -- Stevenson Search Partners, a global life sciences executive search firm, announced today that it received a significant long-term investment from SixSibs Capital, a Milwaukee-based family-owned private investment company, to advance its expansion into a total talent solution company for the global life sciences market.

Stevenson Search Partners

Stevenson Search Partners is an established and trusted executive search advisor servicing the global biotechnology, pharmaceutical, medical technology, contract research organization (CRO) and contract development manufacturing organization (CDMO) sectors.

"Stevenson's long-term focus on quality, culture, diversity and partnership has been our driving force in providing leading-edge talent and services to our partners across the globe," said Adam Bloom, President, Stevenson Search Partners. "We are thrilled with the opportunity to build on our foundation and grow our business with the support and collaboration of SixSibs Capital. Our ability to scale our capabilities is an important next step in our commitment to supporting the remarkable life science professionals who are dedicated to advancing medicines and improving lives."

This new partnership comes during an important time as the life sciences industry faces an emergence of tech bio, precision medicine and digital developments with a rising demand for advancements in science technology and biopharma innovation. This increased need coupled with an aging population and a shortage of innovative, experienced life science executives is propelling the urgency to find and develop the best and brightest leaders.

"Our investment in Stevenson is timely and strategic, driven by the pressing call for innovation in the biopharma industry," said SixSibs Capital President and CEO Jack Wigdale. "With long-term healthcare spending on the rise and a need for skilled human resources, Stevenson's expertise in life sciences talent acquisition, combined with their deep network, positions them perfectly to meet this challenge. By providing additional investment in its people, process and technology, we aim to accelerate Stevenson's growth in executive search, empowering them to leverage advancements and meet the evolving needs of the industry."

With this investment and momentum, Stevenson Search Partners is positioned to grow in the U.S., United Kingdom and Europe. While maintaining its core values, the company aims to expand its services in talent development to continue to foster innovation and growth in the life sciences sector.

About Stevenson Search Partners
With more 40 years of experience, Stevenson Search Partners is a trusted executive search advisor servicing the global biotechnology, pharmaceutical, medical technology, health technology and CRO/CDMO sectors, with offices in the U.S. and the U.K. Dedicated to finding executive talent who will drive innovation across the life sciences industry, Stevenson's expertise includes C-Suite, Research, Clinical, Development, Commercial Manufacturing and Corporate functions, and working with companies ranging from start-ups and academic spinouts to large pharma clients. Stevenson provides a unique collaborative, long-term approach to its clients with a global network and strategic talent mapping and pipelining, and competitive analysis services. Stevenson Search Partners is committed to actively supporting, strengthening and promoting diversity - to its clients, in its own organization, and across the life sciences ecosystem. For more information, visit stevensonsearch.com.

About SixSibs Capital
SixSibs Capital is a family-owned private investment company based in Milwaukee, WI. SixSibs focuses on buy-and-hold investment opportunities, leveraging its patient capital base to partner with management teams to execute their long-term growth plans. The team manages a diverse portfolio, including Private Equity, Venture Capital and Real Estate investments, to create long-term value for its investors and management teams.

Media Contact:
Robin Traum
robintraum@gmail.com

Logo - https://mma.prnewswire.com/media/2353845/Stevenson_Search_Partners_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/stevenson-search-partners-receives-investment-to-spur-growth-as-a-leading-talent-solutions-provider-in-life-sciences-302078962.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.